|4/ANov 27, 7:01 PM ET

Reeg Medical Industries, Inc. 4/A

4/A · Fuse Medical, Inc. · Filed Nov 27, 2018

Insider Transaction Report

Form 4/AAmended
Period: 2018-08-01
Transactions
  • Purchase

    Common Stock

    2018-08-01$0.76/sh+2,539,474$1,930,0006,539,474 total
  • Purchase

    Common Stock

    2018-10-04$0.68/sh+72,139$49,0556,611,613 total
Footnotes (2)
  • [F1]This Form 4/A amends the Form 4 filed by Reeg Medical Industries, Inc. ("RMI") on August 3, 2018, to correct the number of shares of common stock, par value $0.01 (the "Common Stock"), of the Fuse Medical, Inc., a Delaware corporation (the "Company"), that Reeg received pursuant to that certain Securities Purchase Agreement, dated July 30, 2018 (the "Maxim Purchase Agreement"), by and between the Company, Palm Springs Partners, LLC d/b/a Maxim Surgical, a Texas limited liability company ("Maxim"), RMI, Mr. Amir David Tahernia, an individual ("Tahernia", together with RMI, the "Sellers"), and Tahernia in his capacity as the representative of the Sellers (the "Sellers Representative"). The Company made a calculation error when computing the number of shares of Common Stock issued to RMI, and corrected the number in its Current Report on Form 8-K/A filed with the Securities and Exchange Commission (the "SEC") on November 16, 2018 (the "Maxim Form 8-K/A").
  • [F2]On October 4, 2018, the Company issued 72,139 shares of Common Stock to RMI, which represents RMI's pro rata share of the agreed-upon purchase price adjustment pursuant to Pursuant to the Maxim Purchase Agreement, as reported in the Maxim Form 8-K/A.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION